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TEFLON AND AN INCREASED CANCER RISK 
REMAINS UNPROVEN IN HUMANS 
INTRODUCTION 
Jennifer Hitchon, JD, MHA 
Powers Pyles Sutter & Verville, PC 
Washington, DC 
DuPont manufactures a non-stick coating for pans brand-named Teflon. Teflon-
sealed pans make cooking easier - eggs won't stick to the frying pan and cookies won't 
stick to the cookie sheet. Yet researchers have long worried about negative effects of 
Teflon and the chemical compounds used to make it, perfluorooctanoic acid (PFOA): 
is PFOA a carcinogen? Instead of waiting until the Teflon coating sloughs off in black 
flakes, should households get rid of their non-stick pans now and return to using PAM 
and Crisco in mass quantities? 
PFOA is not exclusively used in Teflon; the chemical is also useful in the produc-
tion of fast-food paper containers and stain-resistant fabric coatings. The chemical is 
unique because of how long it lasts in the human body, a fact which perpetuates fears of 
high cancer risks . DuPont has been resistant to these claims, and maintains that while 
PFOA is present during manufacturing, its levels are negligible by the time it reaches the 
kitchen. 
Environmentalists, scientists, toxicologists, and consumer advocacy groups, among 
others, cite numerous short-term animal studies that suggest PFOA increases liver toxic-
ity and risks ofliver, pancreatic, and thymus cancers. Human studies of the chemical's 
effects are more rare - they are mostly limited to studies of workers exposed to high 
levels of PFOA in their factory work environment. Interpreting this data can be difficult, 
however: the workers are exposed to a number of toxic chemicals and they are exposed 
to higher concentrations then the user of a Teflon-coated pan would ever be. And the 
results from animal studies cannot be simplistically transferred to humans - the animals 
are exposed to the chemical in ways humans would never be, and most animal tests 
have been short-term, whereas humans could be exposed to PFOAs across their entire 
lifespan. 
If Teflon can be shown to increase cancer risks, the Environmental Protection 
Agency (EPA) could take steps to regulate or ban the substance, as advisory panels have 
already recommended .1 This would not only cause many Americans to make screening 
appointments with their physician (and lawyer), but would fundamentally alter the way 
we cook and the way we in which we regard advances in cookware. 
The purpose of this study is to review literature on the epidemiologic relationship 
between perfluorooctanoic acid (PFOA) and an increased risk of cancer. 
1 The Environmental Working Group. "PFCs and PFOA: A Family of Chemicals that 
Pollute the Planet." 2006. http:/ /w,vw.ewg.org/reports/pfrworld/index.p hp 
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REVIEW OF LITERATURE 
The question of whether PFOA increases the risk of cancer in humans is difficult to 
scientists, but self-evident in the opinion of consumer-advocacy groups since many non-
epidemiological and non-scientific studies have clearly linked PFOA to cancer. 
First, studies oflaboratory animals have long demonstrated a causal relation-
ship between PFOA exposure and the development of certain cancers. Indeed, PFOA 
belongs to the same family as PFOS (perfluorooctane sulfonates), the active ingredient 
in Scotchgard, which was banned by the EPA in 2000. Both PFOA and PFOS have 
similar chemical and toxic properties: they do not break down in the environment, and 
they cause cancers in laboratory rats and kill newborn rats at doses that do not affect 
mothers.2 
Second, in the 1980s DuPont itself monitored the pregnancies of seven female 
employees at its Teflon plant in Parkersburg, West Virginia. The results of the study were 
not published in a peer-reviewed, scientific journal, but only made public during the 
course oflitigation. According to DuPont, of the seven women, two gave birth to babies 
with birth defects: eye/tear duct defect and nostril/eye defect. 3 To many, this is all the 
evidence they need to start using their cast iron skillets once again. 
Analytic epidemiologic studies, however, are more ambiguous. A 1993 study of 
cancer mortality in employees working at a PFOA-producing factory found a small cor-
relation between employment in PFOA production and prostate cancer ( Gilliland and 
Mandel,1993).4 The study was a retrospective cohort design that looked at 3,537 peo-
ple (2,788 males and 749 females) employed between 1947 and 1983 at an unnamed 
PFOA-producing plant. The study was conducted carefully and with a large sample size, 
but of all the workers studied ( exposed and unexposed) only six died of prostate cancer. 
Of those, four deaths were exposed workers. This led Gilliland and Mandel to con-
clude that 10 years of employment at such a plant is associated with a 3.3-fold increase 
(95% CI, 1.02 to 10.6) in prostate cancer mortality compared with men who were not 
employed in PFOA production . The researchers' interpretation of this finding was that 
if prostate cancer mortality truly is related to PFOA, it is because the chemical alters the 
reproductive hormones of male workers, increasing their prostate cancer mortality rates. 
Gilliland and Mandel collaborated again in 1996 to conduct and publish the results 
of a cross-sectional study of workers at DuPont's Cottage Grove, Minnesota plant 
(Gilliland and Mandel, 1996).5 This time, the two looked at liver cancer in llS occu-
pationally-exposed workers, and - after controlling for the confounder of employment 
length - found no significant associations between PFOA and clinical hepatic toxicity. 
A two-part study, in which Gilliland was also involved, was published in 1998 and 
sought to determine if PFOA exposure led to (1) increased serum estradiol levels, which 
is shown to be linked with cancer in laboratory animals, and (2) increased mortality 
rates from liver, pancreatic, and testicular cancers (Olsen, et al. 1998).6 Two cross-sec-
tional studies were done oflll workers in 1993 and 80 workers in 1995. Olsen, et al. 
measured the levels of serum PFOA in the workers, and found a 10% increase in mean 
estradiol levels in workers with the highest levels of serum PFOA. However, serum 
levels can be confounded by body mass index (BMI) and few subjects were found at the 
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highest and lowest levels of serum, so the researchers were forced to conclude that there 
was not a significant association between PFOA-exposure and risky increases in serum 
estradiol levels. 
For the cancer portion of the study, researchers were also unable to establish a link 
clear enough to impress the EPA. There was no significantly increased cause-specific 
standardized mortality ratio for either male or female employees at the PFOA-producing 
plants. While there were four employee deaths from prostate cancer, compared with only 
1.97 expected (95% confidence interval [CI], 0.55-4.59), only one of those employees 
had worked directly in the PFOA production buildings. Researchers could only conclude 
a link was "biologically plausible."7 
The fifth study in this review was another cross-sectional study of individuals who 
worked in two DuPont plants - one domestic, one overseas. The study was conducted 
in 2000 and published in 2003 as part of the company's fluorochemical medical surveil-
lance program (Olsen, et al. 2003) .8 Researchers did not compare actual cancer rates 
of exposed and unexposed employees, but instead took a cross-section of employees 
and analyzed the presence of serum PFOA concentrations in the blood of the workers. 
Because PFOA is known to cause cancer in laboratory animals at high concentrations, 
and Olsen, et al. sought to determine if those concentrations were present in the hu-
mans directly exposed to PFOA at the factory site. The sample size was 255 employees 
(206 male, 49 female) at the plant in Antwerp, Belgium and 263 employees (215 male, 
48 female) at the plant in Decatur, Alabama. Age, BMI, current alcohol consumption 
( drinks per day) and cigarette use ( cigarettes smoked per day), years worked, and type of 
job (PFOA production versus nonproduction), were potential confounding factors that 
were considered in the analyses. Researchers adjusted for these factors and found that 
the mean serum PFOA concentrations for Decatur employees were 1.32 parts per mil-
lion (men) and 1.78 ppm (women). Mean concentrations were approximately 50% lower 
among Antwerp workers. Because both figures are substantially lower than the amounts 
in laboratory animals that lead to cancer, the researchers concluded that there is no con-
nection between PFOA and an increased risk of cancer. 
SUMMARY AND CONCLUSIONS 
After reviewing the above five studies, one can only say that a link between PFOA 
exposure and an increased risk of cancer is unproven. One study found a small cor-
relation between employment in PFOA production and prostate cancer (Gilliland and 
Mandel, 1993), a second found no significant associations between PFOA exposure and 
liver cancer, specifically ( Gilliland and Mandel, 1996 ), a third found no association be-
tween PFOA exposure and risky increases in serum estradiol levels (Olsen, et al. 1998), 
a fourth found only a "biologically plausible" link between PFOA exposure and cancer 
rates (Olsen, et al. 1998), and a fifth study concluded that there was no connection 
between PFOA and an increased risk of cancer (Olsen, et al. 2003). 
Yet neither DuPont nor consumers can be overconfident in these findings. PFOA, 
the active ingredient in Teflon, is proven to be a carcinogen in laboratory rats, and 
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though epidemiologists have not yet been able to prove that this translates to a similar 
risk for humans, it is because studies are difficult to conduct (they must be very long-
term), and types of controlled studies that would be conclusive would also be unethical 
and indefensible. Many of the studies on people who were occupationally-exposed to 
PFOA were conducted by the same sets of researchers, and all were sponsored in part by 
3M, a chemical supplier to DuPont. The studies have also been small in scope, involving 
so few people that it would have only taken one or two more cancer cases to change the 
link from "no increase" to "statistically significant increase ." 
Additional studies are needed - analytic, long-term studies conducted on people 
with a more common and relevant exposure ( eating food cooked on Teflon-coated 
-eookware) that are objective and not tied to the interests of 3M or DuPont. The studies 
available have only been conducted on people with a decade or more of occupational 
exposure to PFOA, but because PFOA does not break down in the environment or the 
human body, exposure to the chemical over the course of a human 's lifetime must be 
measured, not simply 10 years of exposure (as most of the studies did).9 
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